Lymphangioma diagnostic study of choice

Revision as of 16:29, 18 January 2019 by Mmir (talk | contribs) (→‎Overview)
Jump to navigation Jump to search

Lymphangioma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Lymphangioma from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Lymphangioma diagnostic study of choice On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Lymphangioma diagnostic study of choice

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Lymphangioma diagnostic study of choice

CDC on Lymphangioma diagnostic study of choice

Lymphangioma diagnostic study of choice in the news

Blogs on Lymphangioma diagnostic study of choice

Directions to Hospitals Treating Lymphangioma

Risk calculators and risk factors for Lymphangioma diagnostic study of choice

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Badria Munir M.B.B.S.[2] Haytham Allaham, M.D. [3]

Overview

Lymphangioma is generally diagnosed with non invasive techniques, primarily ultrasound and MRI. However, X-ray often mark the presence of cystic mass, but then is confirmed with ultrasound and MRI. In addition to that micropathology is confirmed with biopsy and histopathology.

Diagnostic Study of Choice

Biopsy:

Biopsy is used to analyze the structure of tissue.

It shows:[1]

Histochemical staining:

MRI:

  • MRI is primarily used for the diagnosis of lymphangioma.
  • MRI can mar the degree of involvement and extent of lesion.
  • MRI can prevent extensive, incomplete surgical resection, because poorly removed lesion can lead to recurrence.

References

  1. 1.0 1.1 Shahi M, Bagga PK, Mahajan NC (October 2009). "Cervical cystic lymphangioma in an adult, diagnosed on FNAC". J Cytol. 26 (4): 164–5. doi:10.4103/0970-9371.62191. PMC 3168007. PMID 21938186.
  2. Sauter, Birthe; Foedinger, Dagmar; Sterniczky, Barbara; Wolff, Klaus; Rappersberger, Klemens (2016). "Immunoelectron Microscopic Characterization of Human Dermal Lymphatic Microvascular Endothelial Cells: Differential Expression of CD31, CD34, and Type IV Collagen with Lymphatic Endothelial Cells vs Blood Capillary Endothelial Cells in Normal Human Skin, Lymphangioma, and Hemangioma In Situ". Journal of Histochemistry & Cytochemistry. 46 (2): 165–176. doi:10.1177/002215549804600205. ISSN 0022-1554.